Small animals support a wide range of pathological phenotypes and genotypes as versatile,
affordable models for pathogenesis of cardiovascular diseases and for exploration of …

In this paper, we report the development of a wireless, passive, biocompatible, and flexible
system for stimulation of human induced pluripotent stem cell derived cardiomyocytes …

Results Data indicated moderate to low levels of fatigue. Furthermore, women (median: 24,
p= 0.001), those with primary school education (median: 21, p= 0.001), those who were “a …

Objectives: Contrast the physics of an artificial pacemaker with the heart's intrinsic
pacemaker. Identify patients that might benefit from a pacemakers. Review the potential for …

Although studies have evaluated the quality of life (QoL) of patients undergoing permanent
pacemaker (PPM) placement, their results are inconsistent. To assess arrhythmia …

Assessing the quality of life for patients pre/post pacemaker implantation can help nurses
better understand how disease and treatment affect patients' lives. Aim: The aim of this study …

Objective Postoperative pain is a major issue with subcutaneous implantable cardioverter
defibrillators (S‐ICD). In 2020, we introduced intravenous patient‐controlled analgesia (IV …

Background: One of the main causes of mortality in patients with heart disease is arrhythmia.
A temporary pacemaker is inserted to control arrhythmias, particularly when an intervention …

Abstract Approximately, 92.1 million patients in the US suffer from cardiovascular diseases
with an estimated healthcare cost of over $300 billion; out of which at least one million …

Background: Over 1.3 million patients worldwide have permanent cardiac pacemakers
(PPMs). In the first to third months after implantation, patients with PPM still report problems …